Cipher Pharmaceuticals Inc. (TSX:CPH)
13.09
+0.04 (0.31%)
Nov 19, 2026, 4:00 PM EST
Cipher Pharmaceuticals Revenue
Cipher Pharmaceuticals had revenue of $12.70M USD in the quarter ending September 30, 2026, a decrease of -1.04%. This brings the company's total for the last twelve months to $49.49M, down -1.13% year-over-year. In the year 2025, Cipher Pharmaceuticals had annual revenue of $50.45M with 51.22% growth. That makes Cipher Pharmaceuticals the 28,149th largest company in the world by revenue and 506th in Canada.
Revenue (ttm)
$49.49M
Revenue Growth
-1.13%
P/S Ratio
4.72
Revenue / Employee
$9.90M
Employees
5
Market Cap
332.68M CAD
Revenue by Geography
- United States (U.S.) 33.54M 66.5%
- Canada 16.91M 33.5%
Fiscal year ended Dec 31, 2025 See the full Cipher Pharmaceuticals breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 50.45M | 17.09M | 51.22% |
| Dec 31, 2024 | 33.36M | 12.20M | 57.66% |
| Dec 31, 2023 | 21.16M | 487.00K | 2.36% |
| Dec 31, 2022 | 20.68M | -1.27M | -5.78% |
| Dec 31, 2021 | 21.94M | 336.00K | 1.56% |
| Dec 31, 2020 | 21.61M | -844.00K | -3.76% |
| Dec 31, 2019 | 22.45M | -298.00K | -1.31% |
| Dec 31, 2018 | 22.75M | -17.39M | -43.33% |
| Dec 31, 2017 | 40.14M | 10.49M | 35.38% |
| Dec 31, 2016 | 29.65M | -4.76M | -13.83% |
| Dec 31, 2015 | 34.41M | 5.19M | 17.74% |
| Dec 31, 2014 | 29.22M | 3.83M | 15.08% |
| Dec 31, 2013 | 25.39M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Verano Holdings | 1.20B |
| Vireo Growth | 956.44M |
| Cresco Labs | 924.67M |
| TerrAscend | 379.07M |
| Aurora Cannabis | 314.07M |
| Canopy Growth | 308.32M |
| Auxly Cannabis Group | 175.15M |
| Medexus Pharmaceuticals | 152.84M |
Cipher Pharmaceuticals News
- 6 days ago - What Cipher Pharmaceuticals (CPH) Said on Its Q3 Earnings Call - MarketBeat
- 6 days ago - Cipher Pharmaceuticals Earnings Call Transcript: Q3 2026 - Transcripts
- 6 days ago - Cipher Pharmaceuticals Earnings release: Q3 2026 - Filings
- 6 days ago - Cipher Pharmaceuticals Report: Q3 2026 - Filings
- 6 days ago - Cipher Pharmaceuticals MD&A: Q3 2026 - Filings
- 6 days ago - Cipher Pharmaceuticals Slides: Q3 2026 - Filings
- 6 days ago - CIPHER PHARMACEUTICALS INC Announces Advance In Q3 Profit - Nasdaq
- 3 months ago - Cipher Pharmaceuticals price target lowered to C$20 from C$22 at Stifel - TheFly